caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1356340517

Craig Kessler

PRACTICEMGMC LLCSee all providers at this practice →
Hematology-OncologyWashington, DCI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Craig Kessler's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 5 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
MEDSTAR - GEORGETOWN MEDICAL CENTER, INC.67296
Bhaskar Kallakury
Pathology · Washington, DC
1375
VARGAS, JOSE1119
Quest Diagnostics Incorporated Md
Clinical Laboratory · Baltimore, MD
1140
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
MEDSTAR - GEORGETOWN MEDICAL CENTER, INC.126718
Laboratory Corporation Of America Holdings
Clinical Laboratory · Burlington, NC
30121
Quest Diagnostics Incorporated Md
Clinical Laboratory · Baltimore, MD
1632
KRISHNAN, JAYASHREE1441
Tom Deng
Pathology · Washington, DC
1339
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
279
Unique beneficiaries
—
Total services
396
Distinct HCPCS
6
Medicare payment
$43K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 48 Hematology-Oncology providers in DC — top quintile (cohort median 735).
PRESCRIBING · PART D · 2024
Total Rx claims
405
Beneficiaries
—
Total drug cost
$3.0M
Distinct drugs
12
Brand share
77.8%
Top prescribed drugs
Ruxolitinib Phosphate85 claims
Peginterferon Alfa-2a65 claims
Apixaban63 claims
Tranexamic Acid38 claims
Ropeginterferon Alfa-2b-Njft29 claims
QUALITY · MIPS · 2024
Final MIPS score
83.0
Quality
72.9
Cost
67.8
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.34%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$64K
Payment records
41
By payment type
Travel and Lodging$30K
Consulting Fee$23K
Honoraria$7K
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$4K
Food and Beverage$970